About us
We are a biotechnology company focused on the discovery, design, and development of innovative peptide-based medicines for people who need them.

Our purpose
To change lives with next-generation peptide therapeutics.
Our ambition
To be the world's best peptide drug discovery and development company.




Our focus is innovative peptide R&D
Since our founding in 1998, Zealand Pharma has built a core expertise in the discovery, design, and development of therapeutic peptides. This expertise has led to an R&D pipeline of innovative investigational candidates designed to address a broad range of disease areas.
Our therapeutic focus areas include: obesity, rare diseases, and chronic inflammation.
In obesity, our peptide capabilities place us in a unique position to address a vast global health challenge and positively impact hundreds of millions of lives. Within rare diseases, we have a long-standing commitment to deliver new treatments to patients living with congenital hyperinsulinism and short bowel syndrome. For chronic inflammatory diseases, we are progressing peptide programs focused on high-profile targets shown to be difficult to address with small molecules and antibodies.
Our strategy is to pursue global co-development and commercialization partnerships that complement and extend our capabilities across the value chain to deliver new peptide therapies to people who need them.
26
years in peptide research and development
350+
employees in Denmark and the United States
80%
employees working in R&D and related functions
8+
innovative pipeline candidates targeting four disease areas
Our Zealand DNA
Throughout our 25-year history, we have built a unique company culture where employees are given autonomy to shape their work with a strong focus on a deeper purpose. We live this every day by leveraging our DNA.
We are BOLD. We EMPOWER people. We work as ONE team. We can be TRUSTED.

Meet Zealand's Co-Founder
Hear from one of our co-founders, Bjarne Due Larsen, as he shares his experience of growing up, discovering his love of science, and his path to the founding of Zealand Pharma.

-
Peptide expertise
We have more than 25 years of expertise in discovery, design and development of peptide-based medicines.
-
Partnerships
We engage with partners so that we can focus on our core competencies.
-
Our impact
We have a responsibility to society, our employees, and the environment.

